South Korea's SK Bioscience said on Monday its COVID-19 vaccine facility had obtained European Union Good Manufacturing Practices (GMP) certification.

The certification approves the production and processing line and quality system of SK bioscience's Andong plant, which produces COVID-19 vaccines developed by AstraZeneca Plc and Novavax Inc. It will enable SK to export vaccines to the European markets.